Altogether, we propose a model in which SIRT7 accelerates lung cancer progression by directly interacting with ARF, preventing the association of ARF with NPM, thus causing ARF ubiquitination and proteasomal-dependent degradation. The gene discussed is CDKN2A; the disease is lung carcinoma.